Personalized therapy in renal cell carcinoma: are the different tyrosine kinase inhibitors the same for any patient?. Issue 1 (2nd January 2017)

Record Type:: Journal Article
Title:: Personalized therapy in renal cell carcinoma: are the different tyrosine kinase inhibitors the same for any patient?. Issue 1 (2nd January 2017)
Main Title:: Personalized therapy in renal cell carcinoma: are the different tyrosine kinase inhibitors the same for any patient?
Authors:: Ratta, Raffaele
Prisciandaro, Michele
Procopio, Giuseppe
Abstract:
Is Part Of:: Expert review of precision medicine and drug development. Volume 2:Issue 1(2017)
Journal:: Expert review of precision medicine and drug development
Issue:: Volume 2:Issue 1(2017)
Issue Display:: Volume 2, Issue 1 (2017)
Year:: 2017
Volume:: 2
Issue:: 1
Issue Sort Value:: 2017-0002-0001-0000
Page Start:: 5
Page End:: 7
Publication Date:: 2017-01-02
Subjects:: Axitinib -- kidney cancer -- pazopanib -- renal cell carcinoma -- sorafenib -- sunitinib -- tyrosine kinase inhibitors
Personalized medicine -- Periodicals
Drug development -- Periodicals
615.19005
Journal URLs:: http://www.tandfonline.com/toc/tepm20/current ↗
http://www.tandfonline.com/ ↗
DOI:: 10.1080/23808993.2017.1289066 ↗
Languages:: English
ISSNs:: 2380-8993
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 288.xml